Task: Answer the multiple choice question.
Question: Which drug exhibits a -2.212% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] O=C(CCn1cnnn1)N1CCCC(Nc2ccc(F)cc2)C1
[b] COc1ccc(C(=O)n2cnc3ccccc32)cc1Br
[c] CCN(CC)CCN1CNC(=S)N(c2ccccc2OC)C1
Answer: b. COc1ccc(C(=O)n2cnc3ccccc32)cc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)n2cnc3ccccc32)cc1Br
COc1ccc(C(=O)n2cnc3ccccc32)cc1Br
benzimidazol-1-yl-(3-bromo-4-methoxyphenyl)methanone